Current Report Filing (8-k)
02 4월 2019 - 5:41AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities and Exchange Act of 1934
Date
of Report (Date of earliest event reported): March 28
th
, 2019
Nexeon
Medsystems, Inc.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-55655
|
|
81-0756622
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
1910
Pacific Avenue, Suite 20000
Dallas,
Texas
|
|
75201
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
844-919-9990
|
(Registrant’s
telephone number, including area code)
|
|
Not
applicable
|
(Former
name or former address, if changed since last report.)
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
March 28, 2019, Wes Ditmer resigned from his position as a member of the Board of Directors of Nexeon Medsystems Inc (the “Company”)
effective immediately. Mr. Ditmer’s resignation did not result from any disagreement with the Company on any matter relating
to its operations, policies or practices.
Cautionary
Note Regarding Forward-Looking Statements
This
current report on Form 8-K contains “forward-looking statements” within the meaning of the safe harbor provisions
of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking
statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,”
“seek,” “aim,” “strive,” “believe,” “project,” “predict,”
“estimate,” “expect,” “continue,” “strategy,” “future,” “likely,”
“may,” “might,” “should,” “will,” the negative of these terms, and similar references
to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they
are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies,
projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate
to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and
many of which are outside of our control. A detailed discussion of some of the risks and uncertainties that could cause our actual
results and financial condition to differ materially from the forward-looking statements is described under the caption “Risk
Factors” in our most recent annual report on Form 10-K, along with our other filings with the SEC.
Any
forward-looking statement made by us in this current report on Form 8-K is based only on information currently available to us
and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
/s/
Will Rosellini
|
|
Will
Rosellini
Chairman
and CEO
|
|
|
|
Date:
April 1, 2019
|
|
2
Nexeon Medsystems (CE) (USOTC:NXNN)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Nexeon Medsystems (CE) (USOTC:NXNN)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
Nexeon Medsystems Inc (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Nexeon Medsystems Inc News Articles